Characteristics and prognosis of KI‐1 positive anaplastic large cell lymphoma in Asians

S. C. Lee(National University Hospital), Justin Wong(National University Hospital), Yew Oo Tan(Gleneagles Hospital), M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), Y K Kueh(National University Hospital), S M Chong(National University Hospital)
Australian and New Zealand Journal of Medicine
December 1, 1998
10.1111/j.1445-5994.1998.tb01555.x
Cited by 2

Related Papers

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
|Clinical Cancer Research|2015|799
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
|PubMed|1996|388
High seroprevalence of Epstein–Barr virus in children with multiple sclerosis
|Neurology|2006|225
Clinical multidrug resistance in cancer: A multifactorial problem
|European Journal of Cancer|1996|178
Docetaxel and carboplatin is an active regimen in advancednon-small-cell lung cancer: a phase II study in Caucasian and Asian patients
|Annals of Oncology|2003|106